CVS Health Corporation (NYSE: CVS) reported third quarter 2022 earnings results. Total revenues increased 10% year-over-year to $81.2 billion. Net loss attributable to CVS Health was $3.4 billion, or $2.60 per share, compared to net income of $1.6 billion, or $1.20 per share, in the year-ago quarter. Adjusted EPS amounted to $2.09. For the full […]
“CVS Health Corporation (NYSE: CVS) reported third quarter 2022 earnings results. Total revenues increased 10% year-over-year to $81.2 billion. Net loss attributable to CVS Health was $3.4 billion, or $2.60 per share, compared to net income of $1.6 billion, or $1.20 per share, in the year-ago quarter. Adjusted EPS amounted to $2.09. For the full […]
· November 2, 2022
CVS Health Corporation (NYSE: CVS) reported third quarter 2022 earnings results.
Total revenues increased 10% year-over-year to $81.2 billion.
Net loss attributable to CVS Health was $3.4 billion, or $2.60 per share, compared to net income of $1.6 billion, or $1.20 per share, in the year-ago quarter. Adjusted EPS amounted to $2.09.
For the full year of 2022, CVS expects adjusted EPS to be $8.55-8.65.
In September, the company entered into an agreement to acquire Signify Health, Inc. for approx. $8 billion. The transaction is expected to close in the first half of 2023.
